News

For reference, Novo Nordisk also offers a highly successful weight loss drug, Wegovy, a GLP-1 receptor agonist.
Altimmune shares cratered more than 50% on Thursday after its experimental obesity drug did not significantly improve liver ...
There have been hundreds of cases of acute pancreatitis in people who have also taken Mounjaro, Ozempic and Wegovy.
W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...
Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug on the market.
Gov. Jeff Landry vetoes a plan to cover costly weight-loss drugs for Louisiana state workers and teachers, citing long-term ...
“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...
As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.
As Ohio cuts off state employees' coverage of medications for weight loss, a lawmaker who has benefited from the drugs wants to bring them back.